Company / Free Cash Flow per Share
CUMBERLAND PHARMACEUTICALS INC Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.35
FY2025
5-year range
$0.19 / $0.58
FY2021-FY2025
Trend
-15.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $0.03 in FY2018 to $0.58 in FY2023.
Based on SEC 10-K filings.
0.35 in FY2025 with a 5-year CAGR of +0.1%.
Declined from $0.58 to $0.35 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -6.4%
- 5-Year CAGR
- +0.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 15.8% year-over-year.
- Peak free cash flow per share was recorded in FY2023.
- Lowest free cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.35 | -15.8% |
| FY2024 | $0.41 | -29.2% |
| FY2023 | $0.58 | +37.4% |
| FY2022 | $0.42 | +125.7% |
| FY2021 | $0.19 | -45.7% |
| FY2020 | $0.35 | +90.4% |
| FY2019 | $0.18 | +565.2% |
| FY2018 | $0.03 | -92.4% |
| FY2017 | $0.36 | -10.5% |
| FY2016 | $0.40 | +952.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026